Are we doing enough to prevent poor-quality antimalarial medicines in the developing world?

BMC Public Health
Erin J WalkerJackson Thomas

Abstract

Malaria is a deadly parasitic disease that affects more than 3 billion people worldwide, in predominantly resource-poor countries. Despite malaria being preventable and treatable, a large number of adults and children, mostly in Africa, die from this disease each year. One contributor to needless morbidity and mortality is the production and distribution of poor-quality antimalarial medicines; indeed, it is estimated that over 122,000 deaths of children under 5 years of age in sub-Saharan countries were caused by poor-quality antimalarial medicines, in 2013 alone. Poor-quality medicines include those that are deliberately falsified for monetary gain and may contain incorrect amounts or even no active ingredients at all, as well as products that are inadequate due to poor compliance to conventional quality standards and medicines that have degraded over time. Across a number of studies it has been reported that 4-92% of antimalarials tested are poor quality. This represents a massive risk to the population subjected to the use of these medicines, in the form of more severe and prolonged illness, additional costs to individuals who already have very little money, and lack of confidence in treatments. The continuing circulation of...Continue Reading

References

Jun 7, 2006·PLoS Medicine·Paul N NewtonNicholas J White
Mar 27, 2009·PLoS Medicine·Paul N NewtonNicholas J White
Feb 2, 2010·Trends in Pharmacological Sciences·Paul N NewtonFacundo M Fernández
Dec 14, 2011·Malaria Journal·Paul N NewtonFacundo M Fernández
May 29, 2012·The Lancet Infectious Diseases·Gaurvika M L NayyarJames Herrington
Jun 19, 2012·Mediterranean Journal of Hematology and Infectious Diseases·Pierre Ambroise-Thomas
Sep 25, 2012·Lancet·Carlos J ChaccourJose L Del Pozo
Oct 1, 2014·The American Journal of Tropical Medicine and Hygiene·Nicola RanieriMark R Witkowski
Oct 12, 2014·The Lancet Global Health·Paul N NewtonFacundo M Fernández
Apr 22, 2015·The American Journal of Tropical Medicine and Hygiene·Gaurvika M L NayyarJoel G Breman
Apr 22, 2015·The American Journal of Tropical Medicine and Hygiene·Patricia TaberneroPaul N Newton
Apr 22, 2015·The American Journal of Tropical Medicine and Hygiene·Shunmay YeungHarparkash Kaur
Apr 22, 2015·The American Journal of Tropical Medicine and Hygiene· Act Consortium Drug Quality Project Team And The Impact Study Team
Apr 22, 2015·The American Journal of Tropical Medicine and Hygiene·John P RenschlerRamanan Laxminarayan
Apr 22, 2015·The American Journal of Tropical Medicine and Hygiene·Yuk Lin YongPaul N Newton
Apr 22, 2015·The American Journal of Tropical Medicine and Hygiene·Mirza LalaniToby Leslie
Apr 22, 2015·The American Journal of Tropical Medicine and Hygiene·Amir Attaran
May 18, 2016·Expert Review of Anti-infective Therapy·Paul N NewtonPhilippe J Guerin
Jun 3, 2016·Malaria Journal·Quique BassatKamal Hamed
May 2, 2017·Transactions of the Royal Society of Tropical Medicine and Hygiene·Oisaemi IzevbekhaiOluseye Bolaji
May 28, 2017·Journal of Pharmaceutical and Biomedical Analysis·James GrechTamsin Kelly

❮ Previous
Next ❯

Software Mentioned

INTERPOL

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.